These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29436980)

  • 21. Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
    Hsu HC; Thomas T; Seibold JR; Thomas TJ
    Agents Actions; 1993; 39 Spec No():C204-6. PubMed ID: 8273569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of ornithine decarboxylase in mutant CHO cells that overproduce the enzyme. Differences between the intracellular distribution of monospecific ornithine decarboxylase antibodies and radiolabeled alpha-difluoromethylornithine.
    Anehus S; Emanuelsson H; Persson L; Sundler F; Scheffler IE; Heby O
    Eur J Cell Biol; 1984 Nov; 35(2):264-72. PubMed ID: 6440787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.
    Pedersen SB; Bjørn SF; Richelsen B; Flyvbjerg A
    Mol Cell Endocrinol; 1995 Jan; 107(1):123-8. PubMed ID: 7796931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression.
    Durante W; Liao L; Peyton KJ; Schafer AI
    Circ Res; 1998 Jul; 83(2):217-23. PubMed ID: 9686762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
    Selamnia M; Mayeur C; Robert V; Blachier F
    Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine.
    Mamont PS; Danzin C; Kolb M; Gerhart F; Bey P; Sjoerdsma A
    Biochem Pharmacol; 1986 Jan; 35(2):159-65. PubMed ID: 3080004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of ornithine decarboxylase in B16 mouse melanoma cells: synergistic activation of melanogenesis by alphaMSH and ornithine decarboxylase inhibition.
    Sanchez Mas J; Martijnez-Esparza M; Bastida CM; Solano F; Penafiel R; Garcija-Borron JC
    Biochim Biophys Acta; 2002 Jan; 1542(1-3):57-65. PubMed ID: 11853879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells.
    Eggstein S; Imdahl A; Kohler M; Waibel M; Farthmann EH
    J Cancer Res Clin Oncol; 1991; 117(1):37-42. PubMed ID: 1997467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyamine-mediated turnover of ornithine decarboxylase in Chinese-hamster ovary cells.
    Glass JR; Gerner EW
    Biochem J; 1986 Jun; 236(2):351-7. PubMed ID: 3092809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
    Shantz LM; Levin VA
    Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
    Raul F
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of diamine oxidase expression by ornithine decarboxylase in isolated rat small bowel enterocytes.
    D'Agostino L; Pignata S; Daniele B; Ferraro C; D'Adamo G; Tritto G; Mazzacca G
    Digestion; 1990; 46 Suppl 2():403-9. PubMed ID: 2124562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).
    Kadmon D
    J Cell Biochem Suppl; 1992; 16H():122-7. PubMed ID: 1289667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyamines in pancreatic growth.
    Fölsch UR; Löser C; Alves F
    Digestion; 1990; 46 Suppl 2():345-51. PubMed ID: 2262066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term reduction of amplified ornithine decarboxylase sequences in human myeloma cells.
    Wahlfors J; Myöhänen S; Korhonen VP; Alhonen L; Jänne J
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):299-303. PubMed ID: 7646459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ornithine decarboxylase as an enzyme target for therapy.
    McCann PP; Pegg AE
    Pharmacol Ther; 1992; 54(2):195-215. PubMed ID: 1438532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornithine decarboxylase and mucosal growth in response to feeding.
    Tabata K; Johnson LR
    Am J Physiol; 1986 Aug; 251(2 Pt 1):G270-4. PubMed ID: 3090896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-difluoromethylornithine-resistant cell lines obtained after one-step selection of Leishmania mexicana promastigote cultures.
    Sánchez CP; Mucci J; González NS; Ochoa A; Zakin MM; Algranati ID
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):847-53. PubMed ID: 9210409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.
    Sarić M; Clarkson AB
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2545-52. PubMed ID: 7872745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
    Kucharzewska P; Welch JE; Svensson KJ; Belting M
    Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.